| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/25/2004 | WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites |
| 03/25/2004 | WO2004024159A1 INHIBITORS OF TFGβ |
| 03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
| 03/25/2004 | WO2004024074A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | WO2004024060A2 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 03/25/2004 | WO2004006927A3 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2004000218A3 Method for making aryl hydrazines and substituted indoles |
| 03/25/2004 | WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis |
| 03/25/2004 | WO2003086318A3 Improved prodrugs of cc-1065 analogs |
| 03/25/2004 | WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003051846A3 Substituted phenyl derivatives |
| 03/25/2004 | WO2003051366A3 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 03/25/2004 | WO2002089797A8 Treatment of adhd |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059118 Which inhibit thrombin |
| 03/25/2004 | US20040059117 Process for producing carbostyril derivatives |
| 03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058978 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs |
| 03/25/2004 | US20040058971 Substituted dipeptides as growth hormone secretagogues |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/25/2004 | US20040058959 Anticoagulants; antiinflammatory agents |
| 03/25/2004 | US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 03/25/2004 | US20040058949 Novel salt and polymorphs of desloratadine hemifumarate |
| 03/25/2004 | US20040058945 N-type calcium channel antagonists for the treatment of pain |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058936 Dietetics, sexual disorders, antidiabetic agents |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058919 Microbiocides |
| 03/25/2004 | US20040058918 Substituted heterocyclic compounds and methods of use |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058905 FKBP inhibitors |
| 03/25/2004 | US20040058877 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058018 Novel substituted benzimidazole dosage forms and method of using same |
| 03/25/2004 | CA2503732A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 03/25/2004 | CA2502583A1 Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same |
| 03/25/2004 | CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | CA2498628A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/25/2004 | CA2498460A1 Inhibitors of tfg.beta. |
| 03/25/2004 | CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 03/25/2004 | CA2498237A1 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | CA2497571A1 Hydantoin derivatives and their use as tace inhibitors |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/25/2004 | CA2494975A1 Substituted 1,4-pyrazine derivatives |
| 03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 03/24/2004 | EP1400521A1 Piperazine compounds |
| 03/24/2004 | EP1400520A1 Crystal of 6- 4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate |
| 03/24/2004 | EP1400519A1 Respiratory syncytial virus replication inhibitors |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1400515A1 Cyclic diamine compound having five-membered cyclic group |
| 03/24/2004 | EP1400513A1 Unsymmetrical cyclic diamine compound |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1400241A1 Fused cyclic compounds and medicinal use thereof |
| 03/24/2004 | EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 03/24/2004 | EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399438A1 Novel heteroaryl derivatives, their preparation and use |
| 03/24/2004 | EP1399436A2 Oxytocin agonists |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399434A1 Novel indole derivatives |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 03/24/2004 | EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399156A2 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity |
| 03/24/2004 | EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 03/24/2004 | EP1399117A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 03/24/2004 | EP1197493B1 Benzimidazole compounds |
| 03/24/2004 | EP1186601B1 Novel isoquinoline derivatives or salts thereof |
| 03/24/2004 | EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1097150B1 Imidazolyl derivatives |
| 03/24/2004 | EP1047690B1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/24/2004 | EP0922036B1 Arylalkanoyl pyridazines |
| 03/24/2004 | CN1484642A Excitatory amino acid receptor antagonists |
| 03/24/2004 | CN1484641A Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1142931C 4-tetrahydropyridylpyrimidine derivatives |
| 03/24/2004 | CN1142929C Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142919C Quinazoline derivatives as antitumor agents |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |